Search results
ESSA Pharma Shares Tank As Janssen Stops Enrollment In EPI-7386 Combo Prostate Cancer Trials
Benzinga via Yahoo Finance· 1 year agoESSA Pharma Inc (NASDAQ: EPIX) announced that Johnson & Johnson's (NYSE: JNJ) Janssen is suspending...
Clovis Oncology's Rubraca Hits Primary Goal In Prostate Cancer Settings
Benzinga via Yahoo Finance· 2 years agoClovis Oncology Inc (NASDAQ: CLVS) announced topline data from the Phase 3 TRITON3 trial,...
Pharma Stock Roundup: FDA Okays PFE & JNJ Drugs, EU Approves ABBV's Migraine Drug
Zacks via Yahoo Finance· 8 months agoFDA approves Pfizer's (PFE) Elrexfio (elranatamab) for RRMM and J&J's (JNJ) oral combination tablet,...
Duran Duran's Andy Taylor on Living with Stage 4 Prostate Cancer: 'I'm Not Giving Up on Life'
People via Yahoo News· 1 year agoCourtesy Andy Taylor Andy Taylor In October 2018, Andy Taylor, a guitarist and founding member of...
Blue Shield of California is promising a simpler, cheaper pharmacy benefits model. Can it deliver?
Healthcare Dive via Yahoo Finance· 6 months agoBig questions hang over the California health insurer's bold experiment — having five vendors carry...
CVS plans to overhaul how drugs are priced
Washington Post via Yahoo Finance· 5 months agoCVS Pharmacy plans to overhaul how it prices prescription drugs, doing away with the complex and often-opaque formulas that typically govern what...
Johnson & Johnson (JNJ) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks via Yahoo Finance· 3 months agoThe headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the...
Pharma Stock Roundup: MRK & Others Post Q1 Results, LLY Drug Shines in Obesity Study
Zacks via Yahoo Finance· 12 months agoMerck (MRK), Eli Lilly (LLY), AstraZeneca (AZN) and others report first-quarter results. J&J (JNJ)...
